Anthem Biosciences IPO Allotment Status: All You Need to Know After Finalization
The Anthem Biosciences IPO Allotment status has finally been released, and investors are eagerly checking whether they’ve got a piece of the much-anticipated public issue. With a strong response from all investor categories and a solid grey market premium (GMP), this IPO has become one of the most talked-about offerings this year.
So, how do you verify if shares have been allotted to you? What are the next steps? Let’s break it all down in simple and clear words.
What is the current Anthem Biosciences IPO Allotment status?
As of July 18, the allotment process has been completed. Investors can now check their IPO allotment status on the official website of KFin Technologies and the BSE India platform.
The IPO, which opened for subscription between July 4 and July 8, received an overwhelming response, particularly from Qualified Institutional Buyers (QIBs) and High Net Worth Individuals (HNIs).
How can you check your Anthem Biosciences IPO Allotment online?
You can check your allotment status through the following steps:
On KFin Technologies (Registrar):
- Visit: https://ris.kfintech.com/ipostatus
- Select Anthem Biosciences IPO from the dropdown.
- Enter your application number, DP ID/Client ID, or PAN number.
- Click on Submit to view your allotment status.
On BSE India:
- Go to: https://www.bseindia.com/investors/appli_check.aspx
- Select Equity, choose Anthem Biosciences, enter your details, and click Search.
How many shares were allotted, and what was the subscription status?
The IPO received heavy interest, with an overall subscription of 48.43 times. The details are:
- QIBs: 116.57 times
- HNIs: 55.46 times
- Retail Investors: 11.11 times
- Employees: 14.94 times
This clearly shows how much trust investors have in Anthem Biosciences’ business model and growth potential.
What is the GMP, and what does it indicate?
As per sources from the grey market, the GMP (Grey Market Premium) for Anthem Biosciences IPO is currently around ₹160 to ₹165. This means the shares are trading at a premium over the issue price in the unofficial market, indicating positive sentiment for a strong listing.
But what does that mean for you?
A high GMP usually hints at a profitable listing day, but it’s important to remember that GMPs are unofficial and can change quickly.
When will the shares be credited to your demat account?
The allotted shares will be credited to investors’ demat accounts by Friday, July 19, 2024, and the listing date is scheduled for Monday, July 22, 2024, on both BSE and NSE
What was the IPO price band and size?
- Price Band: ₹445 to ₹468 per equity share
- Face Value: ₹2 per share
- Lot Size: 32 shares
- IPO Size: ₹3,280 crore
- Fresh Issue: ₹280 crore
- Offer for Sale (OFS): ₹3,000 crore
The company plans to use the fresh issue proceeds mainly for the expansion of its R&D and manufacturing units, which will boost future revenues.
Why was this IPO so popular among investors?
Anthem Biosciences is a leading contract research and manufacturing services (CRAMS) company, offering integrated services for pharmaceutical and biotech companies. Their client list includes global pharma leaders, and their financial performance has shown steady growth.
Also, the rising demand in the CDMO sector, where Anthem operates, made the IPO more appealing. According to Livemint, analysts see huge potential for long-term investors.
What are analysts saying about Anthem Biosciences IPO?
Several market experts have shown positive sentiment. Brokerage firms believe Anthem has a strong pipeline, a competitive edge in biopharma R&D, and solid financials.
Financial Express reports that the company is also backed by Carlyle Group, which holds a significant stake, further boosting investor confidence.
Social Media Buzz
The IPO has generated a lot of excitement online, with investors and analysts sharing insights and predictions:
“Anthem Biosciences IPO sees strong demand; All eyes on listing gains now!” – @medge_prashant
“Anthem Biosciences IPO Allotment out today, GMP holds strong – Listing expected to be premium!” – @ZeeBusiness
Final Thoughts
If you applied for the Anthem Biosciences IPO, this is the right time to check your allotment status and get ready for the listing day. With strong subscription numbers, a high GMP, and backing from top investors, the stock is likely to see good action on debut.
But always keep in mind that the market is dynamic. It’s best to plan your investment strategy after listing, depending on how the stock performs and your long-term goals.
FAQ’S
Check the allotment status online on KFintech or BSE India using your PAN, DP ID, or application number.
A successful IPO indicates an oversubscription and strong investor demand across all categories.
Chances depend on demand; if the IPO is oversubscribed, allotment is done via a lottery system.
It usually takes 3–5 working days after the IPO closes for the allotment status to finalize.
No, IPO allotments are not on a first-come, first-served basis; they are processed through a lottery system if oversubscribed.
There’s no guaranteed trick, but applying from multiple demat accounts and at the cut-off price may improve chances.
Allotment status is usually updated in the evening on the registrar and BSE websites on the finalization day.
Yes, an IPO can fail if it does not receive enough subscriptions or lists at a discount to its issue price.
Historically, IPOs like IRCTC, Paras Defence, and Sigachi have delivered extremely high listing returns.
Disclaimer
This content is for informational purposes only and not financial advice. Always conduct your research.